{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:38:59Z","timestamp":1791283139826,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T00:00:00Z","timestamp":1391558400000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Abbott"},{"name":"Boehringer-Ingelheim"},{"name":"Bristol-Myers Squibb"},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015756","name":"Janssen-Cilag","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Merck-Sharpe & Dohme-Chibret"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jacc.2012.06.063","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T18:13:24Z","timestamp":1359396804000},"page":"511-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":238,"title":["HIV and Coronary Heart Disease"],"prefix":"10.1016","volume":"61","author":[{"given":"Franck","family":"Boccara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Meuleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Ederhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Mary-Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Capeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2012.06.063_bib1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","article-title":"Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population","volume":"24","author":"Lang","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archinternmed.2010.197","article-title":"Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4","volume":"170","author":"Lang","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/eurheartj\/ehq483","article-title":"Cardiovascular implications from untreated human immunodeficiency virus infection","volume":"32","author":"Baker","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.063_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/QAI.0b013e31817efb54","article-title":"Changes in causes of death among adults infected by HIV between 2000 and 2005: The \u201dMortalite 2000 and 2005\u201d surveys (ANRS EN19 and Mortavic)","volume":"48","author":"Lewden","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2012.06.063_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2012.06.063_bib8","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2012.06.063_bib9","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(05)79053-X","article-title":"Severe premature coronary artery disease with protease inhibitors","volume":"351","author":"Henry","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.063_bib10","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(98)26026-0","article-title":"Vascular complications associated with use of HIV protease inhibitors","volume":"351","author":"Behrens","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.063_bib11","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(05)78643-8","article-title":"Vascular complications associated with use of HIV protease inhibitors","volume":"351","author":"Gallet","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.063_bib12","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(05)78644-X","article-title":"Vascular complications associated with use of HIV protease inhibitors","volume":"351","author":"Vittecoq","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.063_bib13","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1097\/00002030-199909100-00034","article-title":"Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment?","volume":"13","author":"Jutte","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib14","first-page":"329","article-title":"Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study","volume":"5","author":"Rickerts","year":"2000","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jacc.2012.06.063_bib15","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.063_bib16","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib17","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men","volume":"17","author":"Mary-Krause","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib18","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200409030-00010","article-title":"Cardio- and cerebrovascular events in HIV-infected persons","volume":"18","author":"d'Arminio","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib19","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/518285","article-title":"Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study","volume":"44","author":"Obel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/324745","article-title":"Ischemic cardiovascular disease in persons with human immunodeficiency virus infection","volume":"34","author":"David","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00126334-200208150-00002","article-title":"Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?","volume":"30","author":"Klein","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2012.06.063_bib23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-1293.2003.00138.x","article-title":"Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study","volume":"4","author":"Law","year":"2003","journal-title":"HIV Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/ciq244","article-title":"No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001\/ALLRT","volume":"52","author":"Ribaudo","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib26","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/QAD.0b013e328349c6ee","article-title":"ABACAVIR use and cardiovascular disease events: a meta-analysis of published and unpublished data","volume":"25","author":"Cruciani","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/QAI.0b013e31826f993c","article-title":"No association of abacavir use with myocardial infarction: findings of an FDA meta-analysis","volume":"61","author":"Ding","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2012.06.063_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/cir269","article-title":"Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era","volume":"53","author":"Bedimo","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0b013e31821d33a5","article-title":"Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Quebec's public health insurance database","volume":"57","author":"Durand","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2012.06.063_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11904-010-0047-3","article-title":"Abacavir and cardiovascular risk: reviewing the evidence","volume":"7","author":"Costagliola","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jacc.2012.06.063_bib31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/375844","article-title":"Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population","volume":"37","author":"Saves","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib32","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/521935","article-title":"Ten-year predicted coronary heart disease risk in HIV-infected men and women","volume":"45","author":"Kaplan","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2012.06.063_bib33","first-page":"23S","article-title":"Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus","volume":"118","author":"Grinspoon","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib34","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00004872-200307000-00028","article-title":"Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome","volume":"21","author":"Gazzaruso","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2012.06.063_bib35","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1097\/HJH.0b013e32830ef5fb","article-title":"Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy","volume":"26","author":"Baekken","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2012.06.063_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/COH.0b013e3281e66919","article-title":"From lipodystrophy and insulin resistance to metabolic syndrome: HIV infection, treatment and aging","volume":"2","author":"Capeau","year":"2007","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","article-title":"Association of C-reactive protein and HIV infection with acute myocardial infarction","volume":"51","author":"Triant","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2012.06.063_bib38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.atherosclerosis.2010.11.013","article-title":"Markers of atherosclerosis and inflammation and mortality in patients with HIV infection","volume":"214","author":"Mangili","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2012.06.063_bib39","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/STROKEAHA.106.479030","article-title":"The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection","volume":"38","author":"Coll","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2012.06.063_bib40","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/QAD.0b013e328300581d","article-title":"Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men","volume":"22","author":"Kaplan","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/cid\/cis489","article-title":"HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals","volume":"55","author":"Lang","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/QAD.0b013e328336098c","article-title":"Platelet function and HIV: a case-control study","volume":"24","author":"Satchell","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/QAI.0b013e3181f7f61a","article-title":"Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection","volume":"56","author":"Baker","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2012.06.063_bib44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.109.898585","article-title":"Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons","volume":"121","author":"Choi","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.063_bib45","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib46","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/eurheartj\/ehq504","article-title":"Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes","volume":"32","author":"Carrillo","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.063_bib47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/HJR.0b013e328336a150","article-title":"Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study","volume":"17","author":"Friis-Moller","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacc.2012.06.063_bib48","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0140-6736(02)09607-1","article-title":"Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study","volume":"360","author":"Lipshultz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.063_bib49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2010.08.620","article-title":"Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study)","volume":"57","author":"Lipshultz","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.063_bib50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ahj.2005.06.012","article-title":"Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study","volume":"150","author":"Fisher","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.06.063_bib51","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.atherosclerosis.2010.04.008","article-title":"Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children","volume":"211","author":"Ross","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2012.06.063_bib52","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1542\/peds.2007-2467","article-title":"Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy","volume":"122","author":"Chantry","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacc.2012.06.063_bib53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/INF.0b013e31820f6575","article-title":"High rate of coronary artery abnormalities in adolescents and young adults infected with human immunodeficiency virus early in life","volume":"30","author":"Mikhail","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jacc.2012.06.063_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(04)00971-5","article-title":"HIV infection, HAART, and endothelial adhesion molecules: current perspectives","volume":"4","author":"de Gaetano Donati","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.thromres.2011.11.022","article-title":"Endothelial and platelet function alterations in HIV-infected patients","volume":"129","author":"Gresele","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2012.06.063_bib56","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2353\/ajpath.2008.070457","article-title":"Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease","volume":"172","author":"Eugenin","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacc.2012.06.063_bib57","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2012.06.063_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.09.025","article-title":"Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis","volume":"185","author":"Fisher","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2012.06.063_bib59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences","volume":"214","author":"Appay","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.jacc.2012.06.063_bib60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0b013e3181e66216","article-title":"Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort","volume":"55","author":"Tien","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2012.06.063_bib61","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib62","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1097\/QAD.0b013e3280108704","article-title":"Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses","volume":"20","author":"Hsue","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib63","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/605578","article-title":"Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy","volume":"49","author":"Ross","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib64","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/QAD.0b013e32832b514b","article-title":"Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis","volume":"23","author":"Hsue","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib65","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1189\/jlb.0809580","article-title":"The macrophage: the intersection between HIV infection and atherosclerosis","volume":"87","author":"Crowe","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jacc.2012.06.063_bib66","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/infdis\/jiq071","article-title":"T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women","volume":"203","author":"Kaplan","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib67","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/infdis\/jiq107","article-title":"Is microbial translocation a cause or consequence of HIV disease progression?","volume":"203","author":"Redd","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib68","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIRCULATIONAHA.107.189624","article-title":"Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy","volume":"118","author":"Currier","year":"2008","journal-title":"Circulation"},{"issue":"Suppl 3","key":"10.1016\/j.jacc.2012.06.063_bib69","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.aids.0000327512.76126.6e","article-title":"Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors","volume":"22","author":"Boccara","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib70","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3851\/IMP1533","article-title":"HIV protease inhibitors activate the adipocyte renin angiotensin system","volume":"15","author":"Boccara","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jacc.2012.06.063_bib71","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.2174\/138161210793563446","article-title":"Adipose tissue as a target of HIV-1 antiretroviral drugs. potential consequences on metabolic regulations","volume":"16","author":"Caron-Debarle","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jacc.2012.06.063_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2007.10.018","article-title":"HIV infection and high density lipoprotein metabolism","volume":"199","author":"Rose","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2012.06.063_bib73","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/QAD.0b013e32834917c6","article-title":"Elevated triglycerides and risk of MI in HIV-positive persons, the D:A:D study","volume":"25","author":"Worm","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib74","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1161\/ATVBAHA.110.213603","article-title":"Premature senescence of vascular cells is induced by HIV protease inhibitors","volume":"30","author":"Lefevre","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2012.06.063_bib75","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s","volume":"52","author":"Torriani","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.063_bib76","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/CIRCULATIONAHA.109.902056","article-title":"Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging","volume":"121","author":"Ragnauth","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.063_bib77","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00134-003-1740-0","article-title":"Coronary artery disease in HIV infected patients","volume":"29","author":"Escaut","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ahj.2003.07.007","article-title":"Acute myocardial infarction in patients infected with human immunodeficiency virus","volume":"147","author":"Varriale","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.06.063_bib79","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9149(03)00631-3","article-title":"Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"92","author":"Ambrose","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.063_bib80","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archinte.163.4.457","article-title":"Acute myocardial infarction in human immunodeficiency virus-infected patients","volume":"163","author":"Matetzky","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib81","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.063_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehq372","article-title":"Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis","volume":"32","author":"Boccara","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.063_bib83","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2125.2008.03332.x","article-title":"Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study","volume":"67","author":"Charbit","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2012.06.063_bib84","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/MJT.0b013e3181ad3437","article-title":"HIV protease inhibitors induced prolongation of the QT Interval: electrophysiology and clinical implications","volume":"17","author":"Singh","year":"2010","journal-title":"Am J Ther"},{"key":"10.1016\/j.jacc.2012.06.063_bib85","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/000331970305400302","article-title":"HIV-associated coronary artery disease","volume":"54","author":"Mehta","year":"2003","journal-title":"Angiology"},{"key":"10.1016\/j.jacc.2012.06.063_bib86","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/hrt.2005.068445","article-title":"Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis","volume":"92","author":"Boccara","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2012.06.063_bib87","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amjcard.2009.03.036","article-title":"Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection","volume":"104","author":"Ren","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.063_bib88","unstructured":"Boccara F, Mary-Krause M, Teiger E, et al. HIV-infected patients have an increased risk of recurrent ischemic events as compared to the general population after an acute coronary syndrome. Presented at: American Heart Association Congress, November 2011, Orlando, FL."},{"key":"10.1016\/j.jacc.2012.06.063_bib89","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurheartj\/ehr456","article-title":"Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy","volume":"33","author":"D'Ascenzo","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.063_bib90","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0003-4975(02)04756-2","article-title":"Cardiac surgery in patients infected with the human immunodeficiency virus","volume":"76","author":"Trachiotis","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2012.06.063_bib91","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1086\/505977","article-title":"Excellent outcomes of cardiac surgery in patients infected with HIV in the current era","volume":"43","author":"Filsoufi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib92","first-page":"276","article-title":"Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study [in Spanish]","volume":"59","author":"Jimenez-Exposito","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jacc.2012.06.063_bib93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/157016208783571900","article-title":"Coronary artery bypass graft in HIV-infected patients: a multicenter case control study","volume":"6","author":"Boccara","year":"2008","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.jacc.2012.06.063_bib94","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1056\/NEJMoa022935","article-title":"Successful cardiac transplantation in an HIV-1-infected patient with advanced disease","volume":"348","author":"Calabrese","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib95","first-page":"968","article-title":"High-urgency priority heart transplantation in HIV-positive patients on life support: breaking barriers?","volume":"30","author":"Boignard","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2012.06.063_bib96","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","volume":"37","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2012.06.063_bib97","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.107.189622","article-title":"State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV\/AIDS: executive summary","volume":"118","author":"Grinspoon","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.063_bib98","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1468-1293.2007.00534.x","article-title":"European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV","volume":"9","author":"Lundgren","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib99","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.063_bib100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002030-200203080-00008","article-title":"Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047","volume":"16","author":"Fichtenbaum","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib101","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAD.0b013e328331d2ab","article-title":"Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial","volume":"24","author":"Aslangul","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib102","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1345\/aph.1M624","article-title":"Pitavastatin: a new HMG-CoA reductase inhibitor","volume":"44","author":"Wensel","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2012.06.063_bib103","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/QAD.0b013e32833068e3","article-title":"Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients","volume":"23","author":"Chow","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib104","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.063_bib105","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/QAD.0b013e328346be29","article-title":"High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors","volume":"25","author":"Aslangul","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2012.06.063_bib106","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2011.02.009","volume":"57","author":"Wright","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.063_bib107","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-150-6-200903170-00009","article-title":"Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force","volume":"150","author":"Wolff","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.06.063_bib108","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/QAI.0b013e3181c8f4c9","article-title":"Increased levels of platelet microparticles in HIV-infected patients with good response to highly active antiretroviral therapy","volume":"54","author":"Corrales-Medina","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2012.06.063_bib109","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.metabol.2011.03.015","article-title":"Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients","volume":"60","author":"Daali","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.jacc.2012.06.063_bib110","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/dmd.110.037143","article-title":"In vitro evaluation of potential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics","volume":"39","author":"Zhou","year":"2011","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712047754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712047754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:56:23Z","timestamp":1760014583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109712047754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0735109712047754"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2012.06.063","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV and Coronary Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2012.06.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}